Events
Join us at our upcoming events to connect with the Annogen team and discover our latest innovations.
EVENTS
Events - Annogen will be attending the ISCT2024 Europe meeting In Gothenburg, Sweden 4-6 September 2024
The renown International Society for Cell Therapy will hold this year's regional event for Europe in Gothenburgh, Sweden. Annogen will be presenting two abstracts on selected advancements in it's R&D portfolio, including validation of its hITA promoter (induced upon T-cell activation) as well as results from AIM-analyses to identify safe harbor expression sites in Jurkat cells. Both these innovations have the ability to substantially improve the safety and effectiveness of cell therapies, the main topic of this event. Reach out to Dr. Martijn Kelder for more information.
.png)
EVENTS
Events - Annogen attending ASGCT in Baltimore, May 7–11, 2024
Request a meeting with Martijn Kelder, Ph.D., Director of Business Development (martijn@annogen.bio) and discuss the applications of:
- SuRE™ human promoters for cell and gene therapy
- CHO genome derived promoters for protein manufacturing, cell culture, and
- AIM™ integration site mapping for cell engineering (allogeneic, cell therapy and cell line generation).
EVENTS
Events - Annogen attending BIO International Convention in San Diego, June 3–6, 2024
Request a partnering meeting with P. Victor Schut, CBO (victor@annogen.bio) and discuss the applications of:
- SuRE™ human promoters for cell and gene therapy
- CHO genome derived promoters for protein manufacturing, cell culture, and
- AIM™ integration site mapping for cell engineering (allogeneic, cell therapy and cell line generation).
EVENTS
Events - Annogen attending BIOEurope in Munich, November 6–8, 2023
Request a partnering meeting with P. Victor Schut, CBO (victor@annogen.bio) and discuss the applications of:
- SuRE™ human promoters for cell and gene therapy
- CHO genome derived promoters for protein manufacturing, cell culture, and
- AIM™ integration site mapping for cell engineering (allogeneic, cell therapy and cell line generation).
EVENTS
Events - Annogen attending the virtual partnering at Alliance for Regenerative Medicine, October 17-18, 2023
Annogen plays a specific role in providing its SuRE™ human promoters (cell specific and/or inducible) and AIM™ integration mapping for cell engineering (e.g. allogeneic platforms).
Looking forward to connecting with senior executives and top stakeholders to tackle the most pressing issues in cell and gene therapies. Please contact (victor@annogen.bio) to learn more about the Annogen qualified promoters and cell engineering capabilities.